Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Nova Ltd (NVMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Nova Ltd — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.4 (market cap $4.59B), while Nova Ltd trades at $366.27 (market cap $11.28B). The key difference: Nova Ltd is far larger — about 2.5× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Nova Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Nova Ltd for 5 Days on average.
| DFTX | NVMI | |
|---|---|---|
Market Cap | $4.59B | $11.28B |
Volume | 2,103,937 | 394,997 |
Sector | Health | Technology |
52-Week High | $48.45 | $605.65 |
52-Week Low | $10.68 | $275.78 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $3.55B | $11.06B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Nova Ltd
Nova provides metrology solutions for semiconductor manufacturing. Its systems measure material and process characteristics to help chipmakers control production across advanced nodes and packaging.
Read more on NVMI →
